Sandoz Egypt introduces OMNITROPE 15mg biosimilar growth hormone for the treatment of short stature    Egypt After 2025: Navigating a Critical Inflection Point    Spot Gold, futures slips on Thursday, July 17th    Egypt's EHA, Huawei discuss enhanced digital health    Egypt expresses condolences to Iraq over fire tragedy    Egypt, Oman discuss environmental cooperation    At London 'Egypt Day', Finance Minister outlines pro-investment policies    Sukari Gold Mine showcases successful public–private partnership: Minister of Petroleum    Egypt's Environment Minister attends AMCEN conference in Nairobi    Egypt's FRA chief vows to reform business environment to boost investor confidence    Egyptian, Belarusian officials discuss drug registration, market access    Syria says it will defend its territory after Israeli strikes in Suwayda    Pakistan names Qatari royal as brand ambassador after 'Killer Mountain' climb    Health Ministry denies claims of meningitis-related deaths among siblings    EU–US trade talks enter 'decisive phase', German politician says    Sri Lanka's expat remittances up in June '25    Egypt's Health Min. discusses drug localisation with Sandoz    Foreign, housing ministers discuss Egypt's role in African development push    Korea Culture Week in Egypt to blend K-Pop with traditional arts    Egypt, France FMs review Gaza ceasefire efforts, reconstruction    CIB finances Giza Pyramids Sound and Light Show redevelopment with EGP 963m loan    Greco-Roman tombs with hieroglyphic inscriptions discovered in Aswan    Egypt reveals heritage e-training portal    Three ancient rock-cut tombs discovered in Aswan    Sisi launches new support initiative for families of war, terrorism victims    Egypt expands e-ticketing to 110 heritage sites, adds self-service kiosks at Saqqara    Egypt's Irrigation Minister urges scientific cooperation to tackle water scarcity    Palm Hills Squash Open debuts with 48 international stars, $250,000 prize pool    Egypt's Democratic Generation Party Evaluates 84 Candidates Ahead of Parliamentary Vote    On Sport to broadcast Pan Arab Golf Championship for Juniors and Ladies in Egypt    Golf Festival in Cairo to mark Arab Golf Federation's 50th anniversary    Germany among EU's priciest labour markets – official data    Cabinet approves establishment of national medical tourism council to boost healthcare sector    Egypt's PM follows up on Julius Nyerere dam project in Tanzania    Paris Olympic gold '24 medals hit record value    A minute of silence for Egyptian sports    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



UK-based pharmaceutical firm to purchase Egypt's EPCI
Multinational Hikma Pharmaceutical to buy Egyptian Company for Pharmaceuticals & Chemical Industries (EPCI)for $22.2 million, company announces Wednesday
Ahram Online Published in Ahram Online on 09 - 01 - 2013

Hikma Pharmaceutical plans to acquire the Egyptian Company for Pharmaceuticals & Chemical Industries (EPCI), according to a Wednesday press release issued by the UK-based multinational.
The company said it would pay LE142.4 million (approximately $22.2 million) for the Egyptian pharmaceutical firm.
Hikma attributed its decision to buy EPCI to the fact that the Egyptian pharmaceutical market represents one of the largest and fastest growing markets in the Middle East/North Africa region.
"Since we entered the Egyptian market in 2007, we have been rapidly growing our presence," Hikma CEO Said Darwazah said. "This acquisition will further accelerate that growth, expanding our product portfolio and adding additional manufacturing capacity and technologies."
IMS Health, a leading provider of information, services and technology for the healthcare industry, estimates that the private retail market in Egypt – currently valued at around $2.3 billion – grew by 10.6 per cent in the 12 months to June 2012.
Hikma, which is listed on the London Stock Exchange, first entered the Egyptian pharmaceutical market in 2007 through its acquisition of Alkan Pharma in Egypt, now Hikma-Egypt.
Hikma-Egypt is currently the seventeenth largest pharmaceutical manufacturer in the country, with an estimated market share of 1.6 per cent.
http://english.ahram.org.eg/News/62099.aspx

Clic here to read the story from its source.